The Sequel II System Sequencer is a high-throughput DNA sequencer machine developed and manufactured by PacBio , and is designed for high throughput, production-scale sequencing laboratories. Originally released in 2015, the Sequel system provides Single Molecule, Real-Time (SMRT) sequencing core...
Filter results
Category
- (-) Computational Research (2)
- (-) Microbiome Science (2)
- Biology (4)
- Human Health (4)
- Scientific Discovery (4)
- Data Analytics & Machine Learning (2)
- Computational Mathematics & Statistics (1)
- Computational Mathematics & Statistics (1)
- Computing & Analytics (1)
- Data Analytics & Machine Learning (1)
- Earth System Science (1)
- National Security (1)
Content type
Dataset Type
Tags
- (-) Long Read Sequencer (2)
- (-) Machine Learning (2)
- Genomics (6)
- Omics (6)
- High Throughput Sequencing (5)
- Sequencer System (5)
- PerCon SFA (3)
- A. pittii SO1 (2)
- Mass spectrometry data (2)
- Proteomics (2)
- Type 1 Diabetes (2)
- 16s (1)
- Alternative Splicing (1)
- Amplicon Sequencing (1)
- Autoimmunity (1)
- Chitin (1)
- DNA Barcode Abundances (1)
- High-Performance Computing (1)
- Mass Spectrometer (1)
- Microbial Isolates (1)
- Photoaffinity Probe Labeling (1)
- Predictive Modeling (1)
- Rhizosphere Soil (1)
- SoDA-PAL Profiling (1)
- Soil (1)
- Sorgoleone bicolor (1)
- Sorgoleone Catabolism (1)
- Statistical Expression Analysis (1)
- Synthetic Biology (1)
- Whole Genome Sequencing (1)
The Sequel II System Sequencer is a high-throughput DNA sequencer machine developed and manufactured by PacBio , and is designed for high throughput, production-scale sequencing laboratories. Originally released in 2015, the Sequel system provides Single Molecule, Real-Time (SMRT) sequencing core...
Inclusion levels of alternative splicing (AS) events of five different varieties (i.e. skipped exon (SE), retained intron (RI), alternative 5’ splice site (A5SS), alternative 3’ splice site (A3SS), and mutually exclusive exons (MXE)) were measured in human blood samples from two separate cohorts of...
Comprised of 6,426 sample runs, The Environmental Determinants of Diabetes in the Young (TEDDY) proteomics validation study constitutes one of the largest targeted proteomics studies in the literature to date. Making quality control (QC) and donor sample data available to researchers aligns with...